hu128.1, a humanized antibody targeting transferrin receptor 1, blocks erythroleukemia growth in xenograft mouse models

Affiliations

• ¹ Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA. [email protected].
• ² Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA.
• ³ Tumor Microenvironment and Resistance to Treatment Laboratory, IRCM, INSERM U1194, Montpellier, France; Université de Montpellier, Montpellier, France; Institut régional du Cancer de Montpellier (ICM)-Val d'Aurelle, Montpellier.
• ⁴ Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Department of Microbiology, Immunology, and Molecular Genetics. David Geffen School of Medicine, UCLA, Los Angeles, CA, USA; UCLA AIDS Institute, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA, USA; The Molecular Biology Institute, UCLA, Los Angeles, CA. [email protected].